NDC 0078-0734 – Ilaris

Canakinumab 150 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC0078-0734

Product details

Brand name
Ilaris
Generic name
Canakinumab
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA125319
Marketed since
December 22, 2016
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Ilaris →

Package NDC codes (1)

Package NDCDescriptionSince
0078-0734-611 VIAL, SINGLE-USE in 1 CARTON (0078-0734-61) / 1 mL in 1 VIAL, SINGLE-USEDec 22, 2016